Grants 360: Patient-Centered Outcomes Research Institute (PCORI)
For more information, visit the event page:
https://publichealth.jhu.edu/node/308831.
Johns Hopkins Bloomberg School of Public Health 2024-11-05 17:00 2024-11-05 18:00 UTC use-title
As part of the research@BSPH Ecosystem initiative, we have launched Grants360 – a series of sessions, panels and workshops to enhance our research community’s pursuit of grant funding. These sessions are devoted to exploring a specific funding mechanism, for which there is notably less awareness than traditional NIH R01 grants, with a panel of successful awardees. Our premise is that by hearing how individuals have successfully developed a proposal for a specific funding mechanism, others can learn and leverage this experience to the benefit of the broader community.
We are hosting a panel of recipients of funding from the Patient-Centered Outcomes Research Institute (PCORI) and are inviting you to participate in the discussion. Ongoing research initiatives at BSPH align well with PCORI’s mission and research investment; however, the number of PCORI-funded investigators is relatively low. PCORI funds studies that can help patients and those who care for them make better-informed healthcare decisions.
Join us on Tuesday, November 5 from 12:00pm-1:00pm for this session at the link below:
Featured Panelists
Holly Wilcox, PhD
Holly Wilcox, PhD '03, MS, uses research to advance public health approaches to suicide prevention, including policies, early intervention, and chain of care approaches.
Kathleen Page, MD
Kathleen Page is an Associate Professor in the Division of Infectious Diseases and International Health at the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Her work focuses on improving access and quality of care to underserved communities.
Renan Castillo, PhD
Renan Castillo, PhD '08, MS, leads a consortium that conducts clinical trials and observational cohorts to study trauma, orthopedics, and disability.
Nilanjan Chatterjee, PhD
Nilanjan Chatterjee, PhD, MS, models disease risk associated with genetic, lifestyle, biomarkers. and other factors, with the goal of improving disease prevention.